Primary Health Properties PLC

Declaration of Voting Results & Voting Rights Announcements • Sep 7, 2021

National Storage Mechanism | Additional information

RNS Number : 8937K

Primary Health Properties PLC

07 September 2021

Primary Health Properties PLC (the "Company" or "PHP")

Admission of new shares and total voting rights

Further to the announcement earlier today by PHP that it has acquired the Crwys Medical Centre for a total consideration of £4.5 million, of which approximately £1.0 million is to be satisfied by the issue of 595,167 new ordinary shares of 12.5 pence each in the capital of PHP to two of the sellers (the "Consideration Shares"), PHP announces that an application was made yesterday for the admission of the Consideration Shares to the premium listing segment of the Official List and to trading on the London Stock Exchange's main market for listed securities ("Admission").

It is expected that Admission and commencement of dealings in the Consideration Shares will become effective at 8.00 a.m. on 9 September 2021. The relevant sellers have agreed not to sell or otherwise transfer the Consideration Shares for a period of 12 months following completion, without the consent of PHP. 

Following Admission and in accordance with the Disclosure and Transparency Rules of the Financial Conduct Authority, the Company will have 1,332,293,152 Ordinary Shares in issue, each share carrying the right to one vote. The Company does not hold any shares in treasury. 

The above figure of 1,332,293,152  Ordinary Shares may be used by shareholders in the Company as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority.

More information on Primary Health Properties PLC can be found on www.phpgroup.co.uk

Further details:

Harry Hyman

Chief Executive Officer

Tel: +44 (0) 20 7451 7050

Richard Howell

Chief Financial Officer

Tel: +44 (0) 20 7104 5599

David Rydell / Steph Watson / Tilly Abraham

(Buchanan Communications)

Tel: +44 (0) 20 7466 5066

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCGZGGLVVRGMZM